|
1. Lung cancer drug doubles survival in trial: What to know Full story
2. Trump calls for vaccine manufacturers to split up doses, repeats autism claim Full story
3. Spreadsheet-based replacement cycles can’t survive this level of capital scrutiny. Hear what can in this webinar.
4. Medicare’s GLP-1 program is ‘far exceeding’ expectations, but a plateau could be coming Full story
5. 2 countries now supply 90% of new US drug ingredient filings: 5 notes Full story
6. Drug shortages, biosimilar pressure, reimbursement erosion, and financial toxicity on patients – the pressures squeezing oncology service lines are the agenda Nov. 4-5 in Chicago at Becker’s Fall Oncology Executive Summit. Apply to attend as a reviewer here.
7. GLP-1s and blindness: 6 things to know Full story
8. FDA holds hearing on psychedelic drugs: 5 things to know Full story
Becker’s Learning Opportunities
9. A specimen left 2 hours at room temperature is already different. See why here.
10. 13% of Medicare Advantage denials met coverage rules. What that means for your appeals here.
11. Wellstar moved flu compliance from 54% to 99% with targeted employee communication. See how here.
12. Becker’s upcoming webinars: between-visit oncology care, revenue cycle scaling and consumer AI. See the sessions here.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
